Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Beam Therapeutics Inc.(BEAM) | 2,266,934 | 2,266,934 | 0 | $44.27M | $38.56M | 74.30% | -$5.71M |
| Lyell Immunopharma, Inc.(LYEL) | 20,162,332 | 1,008,116 | -19,154,216 | $10.85M | $8.91M | 17.17% | -$1.94M |
| Prime Medicine, Inc.(PRME) | 1,792,210 | 1,792,210 | 0 | $3.57M | $4.43M | 8.53% | +$860.3K |